125 related articles for article (PubMed ID: 33761453)
1. NleB/SseKs ortholog effectors as a general bacterial monoglycosyltransferase for eukaryotic proteins.
Koh E; Cho HS
Curr Opin Struct Biol; 2021 Jun; 68():215-223. PubMed ID: 33761453
[TBL] [Abstract][Full Text] [Related]
2. Bacteria-Catalyzed Arginine Glycosylation in Pathogens and Host.
Pan X; Luo J; Li S
Front Cell Infect Microbiol; 2020; 10():185. PubMed ID: 32411621
[TBL] [Abstract][Full Text] [Related]
3. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.
Koh E; Kim U; Cho HS
Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343
[TBL] [Abstract][Full Text] [Related]
4. Structural insights showing how arginine is able to be glycosylated by pathogenic effector proteins.
Park JB; Yoo Y; Cho HS
BMB Rep; 2018 Dec; 51(12):609-610. PubMed ID: 30463645
[TBL] [Abstract][Full Text] [Related]
5. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
[TBL] [Abstract][Full Text] [Related]
6. Sweet Talk: Protein Glycosylation in Bacterial Interaction With the Host.
Lu Q; Li S; Shao F
Trends Microbiol; 2015 Oct; 23(10):630-641. PubMed ID: 26433695
[TBL] [Abstract][Full Text] [Related]
7. An intra-bacterial activity for a T3SS effector.
El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR
Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499
[TBL] [Abstract][Full Text] [Related]
8. NleB/SseK effectors from
El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine-modifying glycosylation by Yersinia effectors.
Schneider S; Wirth C; Jank T; Hunte C; Aktories K
J Biol Chem; 2024 Jun; 300(6):107331. PubMed ID: 38703997
[TBL] [Abstract][Full Text] [Related]
10. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
[TBL] [Abstract][Full Text] [Related]
11. Bacterial glycosyltransferase toxins.
Jank T; Belyi Y; Aktories K
Cell Microbiol; 2015 Dec; 17(12):1752-65. PubMed ID: 26445410
[TBL] [Abstract][Full Text] [Related]
12. Sugar and Spice Make Bacteria Not Nice: Protein Glycosylation and Its Influence in Pathogenesis.
Valguarnera E; Kinsella RL; Feldman MF
J Mol Biol; 2016 Aug; 428(16):3206-3220. PubMed ID: 27107636
[TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Insights into Host Death Domains Inactivation by the Bacterial Arginine GlcNAcyltransferase Effector.
Ding J; Pan X; Du L; Yao Q; Xue J; Yao H; Wang DC; Li S; Shao F
Mol Cell; 2019 Jun; 74(5):922-935.e6. PubMed ID: 30979585
[TBL] [Abstract][Full Text] [Related]
14. NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.
García-García A; Hicks T; El Qaidi S; Zhu C; Hardwidge PR; Angulo J; Hurtado-Guerrero R
Chem Sci; 2021 Sep; 12(36):12181-12191. PubMed ID: 34667584
[TBL] [Abstract][Full Text] [Related]
15. Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity.
Araujo-Garrido JL; Bernal-Bayard J; Ramos-Morales F
Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32131463
[TBL] [Abstract][Full Text] [Related]
16. Using High-Throughput Experiments To Screen
Lin L; Kightlinger W; Warfel KF; Jewett MC; Mrksich M
ACS Synth Biol; 2024 Apr; 13(4):1290-1302. PubMed ID: 38526141
[TBL] [Abstract][Full Text] [Related]
17. Never say never again: protein glycosylation in pathogenic bacteria.
Benz I; Schmidt MA
Mol Microbiol; 2002 Jul; 45(2):267-76. PubMed ID: 12123443
[TBL] [Abstract][Full Text] [Related]
18. N-Glycosyltransferase from Aggregatibacter aphrophilus synthesizes glycopeptides with relaxed nucleotide-activated sugar donor selectivity.
Kong Y; Li J; Hu X; Wang Y; Meng Q; Gu G; Wang PG; Chen M
Carbohydr Res; 2018 Jun; 462():7-12. PubMed ID: 29609090
[TBL] [Abstract][Full Text] [Related]
19. Structural dissection of unnatural ginsenoside-biosynthetic UDP-glycosyltransferase Bs-YjiC from Bacillus subtilis for substrate promiscuity.
Dai L; Qin L; Hu Y; Huang JW; Hu Z; Min J; Sun Y; Guo RT
Biochem Biophys Res Commun; 2021 Jan; 534():73-78. PubMed ID: 33310191
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenicity factors of bacteria with glycosylating activity].
Tartakovskaia DI; Araslanova VA; Belyĭ IuF
Vestn Ross Akad Med Nauk; 2011; (10):28-31. PubMed ID: 22168036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
